ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.124,08
1,18%
Dow Jones
38.671,23
1,17%
Euro vs US Dollar
1,07735
0,41%
Bitcoin
61.834,06
4,59%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Amicus Therapeutics Inc (FOLD)

  7. Amicus Therapeutics Inc (FOLD) News

FOLD

Amicus Therapeutics (FOLD)

Amicus Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:FOLD
DatumZeitQuelleÜberschriftSymbolFirma
01/05/202413h00GlobeNewswire Inc.Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024NASDAQ:FOLDAmicus Therapeutics Inc
20/03/202412h00GlobeNewswire Inc.Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) ReportNASDAQ:FOLDAmicus Therapeutics Inc
11/03/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/03/202423h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
05/03/202423h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
05/03/202423h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
05/03/202422h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
04/03/202423h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
01/03/202422h39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
01/03/202422h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
01/03/202413h00GlobeNewswire Inc.Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024NASDAQ:FOLDAmicus Therapeutics Inc
28/02/202413h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FOLDAmicus Therapeutics Inc
28/02/202413h00GlobeNewswire Inc.Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
20/02/202423h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
20/02/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
20/02/202423h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
15/02/202422h22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
15/02/202422h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
15/02/202422h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
15/02/202413h00GlobeNewswire Inc.Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024NASDAQ:FOLDAmicus Therapeutics Inc
14/02/202422h38Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:FOLDAmicus Therapeutics Inc
14/02/202422h26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:FOLDAmicus Therapeutics Inc
14/02/202415h22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:FOLDAmicus Therapeutics Inc
08/02/202422h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
08/02/202413h00GlobeNewswire Inc.Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™NASDAQ:FOLDAmicus Therapeutics Inc
06/02/202422h15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/02/202401h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/02/202401h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
01/02/202422h45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
01/02/202422h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FOLD

Kürzlich von Ihnen besucht

NYSE
JPM
JP Morgan Chase
PM
XAUUSD
Gold vs US Dollar
NYSE
XOM
Exxon Mobil
TG
RHM
Rheinmetall
NYSE
NKE
Nike
FX
EURUSD
Euro vs US Dollar
AMEX
XLE
Energy Select Sector SPDR
CCOM
US100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US500
US 500
AMEX
SPY
SPDR S&P 500
TG
LHA
Deutsche Lufthansa
USOTC
BASFY
BASF (QX)
TG
DTE
Deutsche Telekom
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten